Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid
US-2024277817-A1 · Aug 22, 2024 · US
This page is not indexed by search engines while we improve data quality.
Bjerregaard Simon patents
Bjerregaard Simon is listed as an inventor on 19 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Bjerregaard Simon |
| Total patents | 19 |
| First publication | Oct 1, 2015 |
| Latest publication | Aug 22, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid
US-2023302092-A1 · Sep 28, 2023 · US
Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
US-11622996-B2 · Apr 11, 2023 · US
Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
US-2023087952-A1 · Mar 23, 2023 · US
Solid compositions comprising a pcsk9 inhibitor and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid
US-2023000949-A1 · Jan 5, 2023 · US
Solid compositions comprising a glp-1 agonist, an sglt2 inhibitor and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid
US-2022395559-A1 · Dec 15, 2022 · US
Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid
US-2022313786-A1 · Oct 6, 2022 · US
Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
US-11382957-B2 · Jul 12, 2022 · US
Solid glp-1 derivative compositions for oral administration
US-2022016216-A1 · Jan 20, 2022 · US
Solid glp-1 derivative compositions for oral administration
US-11167014-B2 · Nov 9, 2021 · US
Recent patents
Latest publications not already listed above.
Tablet formulation comprising a glp-1 peptide and a delivery agent
US-2021275458-A1 · Sep 9, 2021 · US
Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
US-2021236601-A1 · Aug 5, 2021 · US
Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid
US-2021177944-A1 · Jun 17, 2021 · US
Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl) amino) caprylic acid
US-10960052-B2 · Mar 30, 2021 · US
Solid compositions for oral administration
US-2020147179-A1 · May 14, 2020 · US
Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
US-10086047-B2 · Oct 2, 2018 · US
Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid
US-2016151462-A1 · Jun 2, 2016 · US
Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
US-9278123-B2 · Mar 8, 2016 · US
Fatty acid acylated amino acids for oral peptide delivery
US-2015273069-A1 · Oct 1, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Novo Nordisk As | 19 |
| Sauerberg Per | 1 |
| Bjerregaard Simon | 1 |
| Nielsen Flemming Seier | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K38/26 | 18 |
| A61P3/10 | 18 |
| A61K9/0053 | 17 |
| A61P3/04 | 17 |
| A61K9/2013 | 15 |